Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer

Osama Mohammad Ali ElDamshety

Status: Unknown

Conditions: Low Rectal Cancer

Treatments: Procedure: transanal minimally invasive locoregional resection; Procedure: Transanal minimally invasive total mesorectal excision

Study type: Interventional

Funder types: Other

Identifiers

NCT02488577

MISS-TRICKR2

Details and patient eligibility

About

Cases with stage T2 N0 low rectal cancer will undergo either Transanal minimally invasive total mesorectal excision or transanal minimally invasive locoregional resection.

Enrollment: 50 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• T2 N0 low rectal cancer

Exclusion criteria

• patients unfit for laparoscopic resection
• Unwilling to share in the study

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

TAMIS TME

Active Comparator group

Description:

T2 N0 Cases which undergo transanal minimally invasive total mesorectal excision.

Treatment:

Procedure: Transanal minimally invasive total mesorectal excision

TAMIS-Local

Active Comparator group

Description:

T2 N0 Cases which will undergo transanal minimally invasive locoregional resection.

Treatment:

Procedure: transanal minimally invasive locoregional resection